BENGALURU (Reuters) – Johnson & Johnson has told Indian regulators that it will soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the Indian Express newspaper reported on Friday.
(Reporting by Sachin Ravikumar in Bengaluru; Editing by Shounak Dasgupta)
